Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs

BACKGROUND: The Global Polio Eradication Initiative plans for coordinated cessation of oral poliovirus vaccine (OPV) use, beginning with serotype 2-containing OPV (i.e., OPV2 cessation) followed by the remaining two OPV serotypes (i.e., OPV13 cessation). The risk of circulating vaccine-derived polio...

Descripción completa

Detalles Bibliográficos
Autores principales: Duintjer Tebbens, Radboud J., Thompson, Kimberly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582727/
https://www.ncbi.nlm.nih.gov/pubmed/26404780
http://dx.doi.org/10.1186/s12879-015-1114-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582727/
https://www.ncbi.nlm.nih.gov/pubmed/26404780
http://dx.doi.org/10.1186/s12879-015-1114-6

Ejemplares similares